Safety and Outcome of Intravenous Thrombolysis in Stroke Patients on Prophylactic Doses of Low Molecular Weight Heparins at Stroke Onset

Simple item page
dc.contributor.authorJurák Lubomírcs
dc.contributor.authorC Cooraycs
dc.contributor.authorMazya M.cs
dc.contributor.authorMikulík R.cs
dc.contributor.authorBrozman Miroslavcs
dc.contributor.authorP Ringlebcs
dc.contributor.authorA Dixitcs
dc.contributor.authorAhmed N.cs
dc.date.accessioned2020-06-08T09:50:49Z
dc.date.available20-09-2020en
dc.date.available2020-06-08T09:50:49Z
dc.date.issued2019cs
dc.date.updated11-02-2020en
dc.format.extent7cs
dc.identifier.doi10.1161/STROKEAHA.118.024575
dc.identifier.issn0039-2499cs
dc.identifier.urihttps://dspace.tul.cz/handle/15240/156722
dc.language.isoengcs
dc.publisherOvid Technologies (Wolters Kluwer Health)cs
dc.publisher.cityUnited Statescs
dc.relation.ispartofStrokeen
dc.relation.ispartofseries0cs
dc.relation.urihttps://www.ncbi.nlm.nih.gov/pubmed/30943884cs
dc.subjectcerebral hemorrhagecs
dc.subjectcomorbiditiescs
dc.subjecthematomacs
dc.subjectheparincs
dc.subjectthrombosiscs
dc.titleSafety and Outcome of Intravenous Thrombolysis in Stroke Patients on Prophylactic Doses of Low Molecular Weight Heparins at Stroke Onsetcs
local.citation.epage1149-1155cs
local.citation.spage1149-1155cs
local.identifier.publikace7531
local.relation.issue5cs
Files
Collections